Viking Therapeutics (NASDAQ: VKTX) and Summit Therapeutics (NASDAQ: SMMT) are both up-and-coming biotechs with no sales ...

Laurus Labs' stock, down over 10% from its 52-week high, shows signs of bottoming out. Analysts suggest a buying opportunity ...

With that in mind, let's examine two pharma stocks that are incredibly cheap and which are worth buying right now, assuming ...

Founded in 1993, The Motley Fool is a financial services company dedicated to making the world smarter, happier, and richer.

The pharmaceutical industry is promising due to AI and biotech innovations enhancing productivity, steady profits amidst ...

According to Insider Monkey’s data, 21 hedge funds held stakes in Taysha Gene Therapies, Inc. (NASDAQ:TSHA) as of Q2, with a ...

No matter what happens, investing in companies that will get through bear markets and perform well over the long run is ...

Noble Financial analyst Robert LeBoyer reiterated a Buy rating on Tonix Pharma (TNXP – Research Report) on October 11 and set a price ...

VanEck Pharmaceutical ETF has shown strong performance but faces near-term downside risks, prompting a rating downgrade to ...

ANI Pharmaceuticals acquired Alimera Sciences, boosting its rare disease segment with a couple of durable ophthalmology ...

Supported by world-class markets data from Dow Jones and FactSet, and partnering with Automated Insights, MarketWatch ...

Indian stock markets poised for a positive start on Monday, driven by global gains and strong sector performance. Sensex and ...